These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 37599063)

  • 1. Adjuvant and neoadjuvant chemotherapy for biliary tract cancer: a review of randomized controlled trials.
    Nakachi K; Gotohda N; Hatano E; Nara S; Takahashi S; Kawamoto Y; Ueno M
    Jpn J Clin Oncol; 2023 Nov; 53(11):1019-1026. PubMed ID: 37599063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine Extends Survival for Biliary Tract Cancer.
    Cancer Discov; 2017 Jul; 7(7):OF1. PubMed ID: 28572460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adjuvant and neoadjuvant therapy for resectable biliary tract cancer.
    Nara S; Esaki M; Ban D; Takamoto T; Mizui T; Shimada K
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):537-545. PubMed ID: 33793366
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in adjuvant therapy of biliary tract cancer: an overview of current clinical evidence based on phase II and III trials.
    Belkouz A; Wilmink JW; Haj Mohammad N; Hagendoorn J; de Vos-Geelen J; Dejong CHC; Homs MYV; Groot Koerkamp B; van Gulik TM; van Oijen MGH; Punt CJA; Klümpen H
    Crit Rev Oncol Hematol; 2020 Jul; 151():102975. PubMed ID: 32464483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Landmark Series: Gallbladder Cancer.
    Gamboa AC; Maithel SK
    Ann Surg Oncol; 2020 Aug; 27(8):2846-2858. PubMed ID: 32474816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in biliary tract cancer: state of the art and future perspectives.
    Akhoundova Sanoyan D; McNamara MG; Lamarca A; Valle JW
    Curr Opin Oncol; 2020 Jul; 32(4):364-369. PubMed ID: 32541326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
    Rizzo A; Brandi G
    Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for resectable biliary tract cancer: current status and future direction.
    Konishi M
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):301-5. PubMed ID: 22262202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network meta-analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence.
    Salani F; Vetere G; Rossini D; Genovesi V; Carullo M; Bartalini L; Massa V; Bernardini L; Caccese M; Cesario S; Graziani J; Grelli G; Mangogna F; Vivaldi C; Masi G; Fornaro L
    Liver Int; 2024 Oct; 44(10):2763-2772. PubMed ID: 39072988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADJUBIL: phase II study of adjuvant immunotherapy with STRIDE regimen with/without capecitabine in biliary tract cancers.
    Goetze T; Gonzalez-Carmona MA; Kochen L; Agaoglu NB; Al-Batran SE; Habibzada T; Pons M; Brunner M; Ettrich TJ; Köhne CH; Roderburg C; Modest D
    Future Oncol; 2024 Feb; 20(6):307-315. PubMed ID: 38410920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemotherapy in biliary tract cancer patients: A systematic review and meta-analysis of randomized controlled trials.
    Caparica R; Bruzzone M; Hachem GE; Ceppi M; Lambertini M; Glasberg J; de Azambuja E; Van Laethem JL; Hendlisz A
    Crit Rev Oncol Hematol; 2020 May; 149():102940. PubMed ID: 32252001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline.
    Shroff RT; Kennedy EB; Bachini M; Bekaii-Saab T; Crane C; Edeline J; El-Khoueiry A; Feng M; Katz MHG; Primrose J; Soares HP; Valle J; Maithel SK
    J Clin Oncol; 2019 Apr; 37(12):1015-1027. PubMed ID: 30856044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of chemotherapy in treatments for biliary tract cancer.
    Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine: Still a Standard Option in the Adjuvant Setting of Biliary Tract Cancer?
    Edeline J; Malka D
    J Clin Oncol; 2022 Nov; 40(31):3667-3668. PubMed ID: 35786978
    [No Abstract]   [Full Text] [Related]  

  • 17. Postoperative adjuvant treatments for biliary tract cancer.
    Furuse J
    J Hepatobiliary Pancreat Surg; 2008; 15(5):463-7. PubMed ID: 18836797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant treatments in biliary tract cancer: an analysis based on restricted mean survival time.
    Messori A; Bartoli L; Trippoli S
    Dig Liver Dis; 2020 Oct; 52(10):1208-1209. PubMed ID: 32505564
    [No Abstract]   [Full Text] [Related]  

  • 19. Overview of adjuvant and neoadjuvant therapy for resectable gastric cancer in the East.
    Fujitani K
    Dig Surg; 2013; 30(2):119-29. PubMed ID: 23867588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral versus intravenous fluoropyrimidines for colorectal cancer.
    Chionh F; Lau D; Yeung Y; Price T; Tebbutt N
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008398. PubMed ID: 28752564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.